WINDTREE THERAPEUTICS INC /DE/ 8-K

What Happened
Windtree Therapeutics, Inc. (WINT) announced via a Form 8-K filed January 7, 2026 that Eric L. Curtis resigned as President and Chief Operating Officer, effective immediately on January 5, 2026. The company disclosed the departure under Item 5.02 (Departure of Directors or Certain Officers).

Key Details

• Officer: Eric L. Curtis, President and Chief Operating Officer.
• Resignation effective: January 5, 2026.
• Filed: Form 8-K submitted January 7, 2026 (Item 5.02).
• Additional disclosure: The filing does not describe a reason for the resignation or identify a successor or any related arrangements.

Why It Matters
A sudden departure of a President/COO is a material leadership change that investors should note because it can affect company operations and execution of strategy. Windtree has filed the required 8-K; investors should watch for subsequent updates from the company about a successor, interim management, or any related financial arrangements. Keywords: leadership change, COO, President, 8-K, executive resignation.